

Tykerb 250mg Tablet (Lapatinib)
Manufactured By
Glaxo smithkline pharmaceuticals
Pack Of
30
Salt Composition
Lapatinib
Storage
Keep in cold place
Fast Delivery

Easy Returns

Secure Payments

Up to 60% Discounts
Overview
Tykerb 250mg Tablet is an anticancer medicine with active ingredient Lapatinib. It is prescribed to treat advanced or HER2 Positive metastatic breast cancer alone or in combination with some other drugs. Lapatinib works as a dual tyrosine kinase inhibitor as it block the action of HER2 and EGFR to control the growth of cancer cells. It should be taken in dosage as advice by the doctor on an empty stomach.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | tykerb |
| Generic / Active Ingredient | Lapatinib |
| Strength | 250 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | glaxo smithkline pharmaceuticals |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Breast Cancer |
Uses and Indications
Breast Cancer
Side Effects of Tykerb 250mg Tablet
Tykerb 250mg Tablet(Lapatinib 250mg) is a strong anticancer medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.
Some common side effects include:
● Abdominal pain
● Back pain
● Breathing problems
● Constipation
● Cough
● Diarrhea
● Fatigue
● Headache
● Hot flashes
● Increased bilirubin in the blood
● Insomnia (difficulty in sleeping)
● Joint pain
● Liver damage
● Loss of appetite
● Mucosal inflammation
● Nausea
● Pain in extremities
● Rash
Tykerb 250mg Tablet Dosage and How To Take It
Take Tykerb 250mg Tablet(Lapatinib 250mg) in dosage as prescribed by the doctor. Dosage and the duration determined as per the patients health condition. This tablet should be swallowed as a whole with water. Don't crush, chew, or break the tablet. It should be taken on an empty stomach. Never skip a dose or double dose.
Safety Advice for Tykerb 250mg Tablet
- ● Alcohol: Avoid the consumption of alcohol while taking Tykerb 250mg Tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
- ● Pregnancy: Do not take the Tykerb 250mg Tablet(Lapatinib 250mg) without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
- ● Breastfeeding: Tykerb 250mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby.
- ● Driving: Tykerb 250mg Tablet(Lapatinib 250mg) may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
- ● Kidney: Share your medical history with the doctor before starting the Tykerb 250mg Tablet. Do not take it without consulting a doctor if you have any kidney related issue.
- ● Liver: Share your medical history with the doctor before starting the Tykerb 250mg Tablet(Lapatinib 250mg). Do not take it without consulting a doctor if you have any liver related issue.
FAQs About Tykerb 250mg Tablet
What are the uses of Tykerb 250mg Tablet(Lapatinib 250mg)?
Tykerb 250mg Tablet is a prescription based anticancer medicine used in the treatment of advanced or HER2 Positive metastatic breast cancer alone or in combination with some other drugs
How to take Tykerb 250mg Tablet?
Take Tykerb 250mg Tablet(Lapatinib 250mg) exactly as prescribed by the doctor at a same time each day.
Can a liver or kidney related issue patient can take it?
It is advice to avoid the consumption of Tykerb 250mg Tablet in case of kidney or liver related issues.
How does Tykerb 250mg Tablet work?
Lapatinib works as a dual tyrosine kinase inhibitor as it block the action of HER2 and EGFR to control the growth of cancer cells.
What are the common side effects of taking Tykerb 250mg Tablet?
There are some possible side effects of taking Tykerb 250mg Tablet(Lapatinib 250mg) such as abdominal pain, back pain, breathing problems, constipation, cough, diarrhea, fatigue, headache, etc.
References
● Gril, B., Palmieri, D., Bronder, J. L., Herring, J. M., Vega-Valle, E., Feigenbaum, L., ... & Steeg, P. S. (2008). Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. Journal of the National Cancer Institute, 100(15), 1092-1103.
● D’Amato, V., Raimondo, L., Formisano, L., Giuliano, M., De Placido, S., Rosa, R., & Bianco, R. (2015). Mechanisms of lapatinib resistance in HER2-driven breast cancer. Cancer treatment reviews, 41(10), 877-883.
● Opdam, F. L., Guchelaar, H. J., Beijnen, J. H., & Schellens, J. H. (2012). Lapatinib for advanced or metastatic breast cancer. The oncologist, 17(4), 536-542.
● Moy, B., & Goss, P. E. (2006). Lapatinib: current status and future directions in breast cancer. The oncologist, 11(10), 1047-1057.
● Bilancia, D., Rosati, G., Dinota, A., Germano, D., Romano, R., & Manzione, L. (2007). Lapatinib in breast cancer. Annals of oncology, 18, vi26-vi30.
● Higa, G. M., & Abraham, J. (2007). Lapatinib in the treatment of breast cancer. Expert review of anticancer therapy, 7(9), 1183-1192.
Marketer Details
Glaxo smithkline pharmaceuticals
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


